Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2023-09-21 00:00:00 ET · period of report 2023-09-19 · accession 0001209191-23-050259 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-21 | 2023-09-19 | VRTX | Bozic Carmen | EVP, CMO | S - Sale | $351.00 | -5,651 | 51.9K | -10% | -$1.98M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-19 | S | D | 5,651 | $351.00 | 51,905 | D | — | — |